Li Cao

This paper introduces CATIPs, covalently anchored tumor immunotherapeutic proteins that enhance antitumor immunity by immobilizing immune cues on tumor surfaces, showing improved efficacy and reduced toxicity in preclinical models.

This paper identifies covalent cyclic peptide inhibitors targeting protein-protein interactions using phage display, demonstrating antiviral activity against SARS-CoV-2.

This paper identifies cysimiditides, a new class of RiPPs with a Zn-tetracysteine motif and aspartimidylation, showing their biosynthesis and structural features.

This paper develops covalent nanobodies using a PERx mechanism to neutralize SARS-CoV-2 and variants with greatly increased potency.